Skip to content
10-Q

Quarterly Report

BIOXYTRAN, INC. BIXT

0001493152-25-023399

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 99.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 88.99M sh
Shares Diluted Q3 2025 · Sep 30, 2025 88.94M sh
Shares Diluted Q3 2025 · Sep 30, 2024 126.39M sh
Shares Diluted Q3 2025 · Sep 30, 2024 153.82M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$289.48K
Operating Cash Flow restated Q3 2025 · Sep 30, 2024 −$253.38K
Current Liabilities Q3 2025 · Sep 30, 2025 $3.06M
Current Liabilities Q3 2025 · Dec 31, 2024 $1.93M
Total Liabilities Q3 2025 · Sep 30, 2025 $3.06M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.93M
Current Assets Q3 2025 · Sep 30, 2025 $14.5K
Current Assets Q3 2025 · Dec 31, 2024 $5.15K
Total Assets Q3 2025 · Sep 30, 2025 $156.29K
Total Assets Q3 2025 · Dec 31, 2024 $138.69K
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.02
Eps Diluted Q3 2025 · Sep 30, 2024 $0.00
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 −$0.02
Eps Basic Q3 2025 · Sep 30, 2024 $0.00
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Rd Expense Q3 2025 · Sep 30, 2025 $452K
Rd Expense Q3 2025 · Sep 30, 2024 $51K
Rd Expense Q3 2025 · Sep 30, 2024 $78K
Net Income Q3 2025 · Sep 30, 2025 −$282.73K
Net Income Q3 2025 · Sep 30, 2025 −$1.6M
Net Income Q3 2025 · Jun 30, 2025 $35.44K
Net Income Q3 2025 · Mar 31, 2025 −$1.35M
Net Income Q3 2025 · Sep 30, 2024 −$392.37K
Net Income restated Q3 2025 · Sep 30, 2024 −$1.61M
Net Income restated Q3 2025 · Jun 30, 2024 −$661.65K
Net Income restated Q3 2025 · Mar 31, 2024 −$560.52K
Operating Income Q3 2025 · Sep 30, 2025 −$496.01K
Operating Income Q3 2025 · Sep 30, 2025 −$1.24M
Operating Income Q3 2025 · Sep 30, 2024 −$346.2K
Operating Income restated Q3 2025 · Sep 30, 2024 −$1.73M